Home|Journals|Articles by Year|Audio Abstracts
 

Research Article



In vitro antioxidant and cytochrome p450 inhibitory activity of dark chocolate mediated zinc oxide nanoparticles

Prenetha,R.V.Geetha*,R.P.Parameswari,T. Lakshmi.




Abstract

Dark chocolate provides enormous health benefits owing to its enriched antioxidants, such as polyphenols and flavonoids,
which can encounter free radicals in the body. These antioxidants can lower blood cholesterol, lowering your risk of heart
attacks, cancer, high blood pressure, and stroke. This study was aimed to investigate both the free radical scavenging
property and inhibitory property of dark chocolate mediated zinc oxide nanoparticles on activity of cytochrome P450 (CYP)
isoform. The DC-ZnO was evaluated against free radicals formation using DPPH and ABTS free radical assays. Besides, the
ZnO nanoparticles were also evaluated for CYP34A inhibitory activity. From the results it was demonstrated that there
was a dose dependent increase in the inhibition of DPPH and ABTS free radicals and CYP3A4 inhibitory activity by the dark
chocolate formulation mediated zinc oxide nanoparticles. The maximum inhibitory activity was observed at maximum
concentration of 160µL. It may be thus concluded that the synthesized dark chocolate mediated zinc oxide nanoparticles
possess potent antioxidant activity with significant inhibitory effect on Cytochrome P3A4 enzyme.

Key words: Dark chocolate, Zinc oxide, DPPH, ABTS,CYP3A4, inhibitions






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.